Hypercholesterolaemia [dsyn]
Lipid [lipd]
lowering [spco]
treatment [ftcn]
Affect [menp]
acute [tmco]
Endogenous [ftcn]
fibrinolytic [topp]
Capacity [qnco]
In Vivo [spco]
Objective [inpr]
acute [tmco]
Tissue Plasminogen Activator [aapp, enzy, phsu]
Release [hlca]
In Vivo [spco]
Patients [podg]
Hypercholesterolaemia [dsyn]
absence [qnco]
Lipid [lipd]
lowering [spco]
treatment [ftcn]
matched [resa]
Design [acty]
Parallel [qlco]
Group [idcn]
Comparison [acty]
DOUBLE BLIND [resa]
cross over [genf]
setting [ftcn]
university hospital [hcro, mnob]
Patients [podg]
Eight [qnco]
Patients [podg]
Hypercholesterolaemia [dsyn]
NMOLE [qnco]
Eight [qnco]
matched [resa]
NMOLE [qnco]
Methods [inpr]
Blood flow [orgf]
Plasma [bdsu]
fibrinolytic [topp]
Measured [qlco]
Forearms [bpoc]
Unilateral [spco]
Brachial Artery [bpoc]
infusions [topp]
Endothelium [tisu]
Dependent [qlco]
Vasodilator [phsu]
Substance P [aapp, nsba]
pmol [qnco]
Endothelium [tisu]
Independent [idcn]
Vasodilator [phsu]
Sodium Nitroprusside [orch, phsu]
interventions [hlca]
Patients [podg]
measurements [ftcn]
Make [ftcn]
Occasional [tmco]
baseline [bodm]
Six [qnco]
weeks [tmco]
placebo [topp]
Pravastatin [orch, phsu]
mg% [qnco]
Daily [tmco]
Administered [ftcn]
DOUBLE BLIND [resa]
Cross-Over Design [resa]
Main [qlco]
Outcome Measures [qnco]
acute [tmco]
Release [hlca]
Tissue Plasminogen Activator [aapp, enzy, phsu]
Compared [acty]
Patients [podg]
control substance [ftcn]
Subject [grup]
P NOS [aapp, imft]
Dose-dependent [qnco]
increases [ftcn]
Forearm [bpoc]
Blood flow [orgf]
P NOS [aapp, imft]
increases [ftcn]
Plasma [bdsu]
Tissue Plasminogen Activator Antigen [imft]
activity [dora]
Concentrations [menp]
Pravastatin [orch, phsu]
treatment [ftcn]
Patients [podg]
Total Cholesterol [lbpr]
Fall [fndg]
SEM [medd]
NMOLE [qnco]
P NOS [aapp, imft]
Substance P [aapp, nsba]
Induced [ftcn]
Vasodilatation [phsf]
Long [qlco]
Impaired [ftcn]
Comparison [acty]
Reproducibility [qlco]
responses [orga]
Pravastatin [orch, phsu]
treatment [ftcn]
Basal [spco]
Substance P [aapp, nsba]
Induced [ftcn]
Tissue Plasminogen Activator [aapp, enzy, phsu]
Release [hlca]
Conclusions [idcn]
Hypercholesterolaemia [dsyn]
Lipid [lipd]
lowering [spco]
treatment [ftcn]
Demonstrable [ftcn]
effects [qlco]
acute [tmco]
Substance P [aapp, nsba]
Induced [ftcn]
Tissue Plasminogen Activator [aapp, enzy, phsu]
Release [hlca]
In Vivo [spco]
Suggest [idcn]
Benefits [qnco]
Lipid [lipd]
lowering [spco]
treatment [ftcn]
Unlikely [cnce]
mediated [socb]
Improvement [cnce]
Endogenous [ftcn]
Fibrinolysis [phsf]
